Metabolic Profiling Technologies for Biomarker Discovery in Ethnomedicinal Plants for Drug Development

This work explores the complex realm of ethno medicinal plants (EMPs) as rich sources of a multitude of phytochemicals, with a specific emphasis on their potential as primary therapeutic compounds in the pharmaceutical sector. Ethnomedicinal plants, seen as natural sources of bioactive compounds, include a vast amount of secondary metabolites, some of which have not yet been utilized for pharmaceutical purposes. The wide range of chemical frameworks found in these plants, phenylpropanoids and flavonoids to name a couple, provide a valuable resource for logical drug development. Likewise the metabolic transition toward biosynthetic activity in EMPs generates diversified chemicals that have the potential to be used as drugs, including isoprenoids, phenols, and alkaloids. By utilizing advanced metabolic profiling technologies such as UV-Visible spectrophotometry, FTIR spectroscopy, Gas Liquid Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Nuclear Magnetic Resonance (NMR) spectroscopy, a thorough investigation of EMPs can be conducted. By combining these methods with OMICS technologies such as metabolomics, a comprehensive comprehension of the metabolomic makeup is achieved. The discovery and analysis of biomarkers, such as terpenes, phenolics, alcohols, flavonoids, sesquiterpene lactones, and alkaloids, are crucial in revealing the pharmacological capabilities of EMPs. Equipped with sophisticated computational methodologies and analytical techniques, researchers can unearth a vast reservoir of knowledge that has the potential to fundamentally transform the field of drug discovery. By employing an integrative methodology, pharmaceutical compounds concealed within traditional medicinal plants can be uncovered more quickly, and the field of global healthcare could be sustainably enhanced. As such, by providing an expedited pathway to drug discovery, ethnomedicinal plants possess the ability to emerge as pivotal actors in addressing healthcare concerns, consequently augmenting the overall welfare of populations across the globe.